Abivax shareholders can now review May 11 Paris meeting documents

Abivax announced that its Annual Ordinary and Extraordinary General Meeting will be held on May 11, 2026, at 3:00 p.m. CEST in Paris. The company has made the preparatory documents, agenda, and draft resolutions available to shareholders on its website, following their publication in BALO on April 3, 2026. This announcement provides procedural details for the upcoming meeting where shareholders can review important corporate decisions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin